408 evidence-linked molecules — 5 currently mapped to an Abiozen canonical molecule, 403 not yet mapped. Ordering is alphabetical and neutral; this is an evidence view, not a ranking.
Prioritize — inhibition potency (IC50) →| Molecule | Representative activity | Evidence | Abiozen identity | Commercial |
|---|---|---|---|---|
|
CHEMBL96071
CHEMBL96071
|
IC50 242 nM | 1 | Not yet mapped | — |
|
CHEMBL96080
CHEMBL96080
|
IC50 612 nM | 1 | Not yet mapped | — |
|
CHEMBL96113
CHEMBL96113
|
IC50 1000000 nM | 1 | Not yet mapped | — |
|
CHEMBL96160
CHEMBL96160
|
IC50 266 nM | 1 | Not yet mapped | — |
|
CHEMBL96183
CHEMBL96183
|
IC50 3000 nM | 1 | Not yet mapped | — |
|
CHEMBL96229
CHEMBL96229
|
IC50 24200 nM | 1 | Not yet mapped | — |
|
CHEMBL96299
CHEMBL96299
|
IC50 346 nM | 1 | Not yet mapped | — |
|
CHEMBL96395
CHEMBL96395
|
IC50 434000 nM | 1 | Not yet mapped | — |
|
CHEMBL96453
CHEMBL96453
|
IC50 988 nM | 1 | Not yet mapped | — |
|
CHEMBL96459
CHEMBL96459
|
IC50 16 nM | 1 | Not yet mapped | — |
|
CHEMBL96491
CHEMBL96491
|
IC50 282 nM | 1 | Not yet mapped | — |
|
CHEMBL96577
CHEMBL96577
|
IC50 436 nM | 1 | Not yet mapped | — |
|
CHEMBL96593
CHEMBL96593
|
IC50 53 nM | 1 | Not yet mapped | — |
|
CHEMBL96607
CHEMBL96607
|
IC50 372 nM | 1 | Not yet mapped | — |
|
CHEMBL96666
CHEMBL96666
|
IC50 2 nM | 1 | Not yet mapped | — |
|
CHEMBL96748
CHEMBL96748
|
IC50 192 nM | 1 | Not yet mapped | — |
|
CHEMBL96814
CHEMBL96814
|
IC50 7400 nM | 1 | Not yet mapped | — |
|
CHEMBL96890
CHEMBL96890
|
IC50 491 nM | 1 | Not yet mapped | — |
|
CHEMBL96891
CHEMBL96891
|
IC50 109000 nM | 1 | Not yet mapped | — |
|
CHEMBL96892
CHEMBL96892
|
IC50 13 nM | 1 | Not yet mapped | — |
|
CHEMBL96908
CHEMBL96908
|
IC50 24 nM | 1 | Not yet mapped | — |
|
CHEMBL96937
CHEMBL96937
|
IC50 35 nM | 1 | Not yet mapped | — |
|
CHEMBL96942
CHEMBL96942
|
IC50 305 nM | 1 | Not yet mapped | — |
|
CHEMBL97064
CHEMBL97064
|
IC50 190000 nM | 2 | Not yet mapped | — |
|
CHEMBL97180
CHEMBL97180
|
IC50 213000 nM | 2 | Not yet mapped | — |